These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25756576)

  • 1. A multidisciplinary approach in early stent thrombosis: Insights from optical coherence tomography and platelet reactivity testing.
    Hernandez-Perez FJ; Garcia-Touchard A; Restrepo-Cordoba MA; Rodriguez-Gonzalez E; Escudier-Villa JM; Cobo-Marcos M; Alonso-Pulpon L; Goicolea-Ruigomez J
    Int J Cardiol; 2015 Apr; 184():494-496. PubMed ID: 25756576
    [No Abstract]   [Full Text] [Related]  

  • 2. Optical coherence tomography-guided treatment of very late stent thrombosis caused by inaccurate stent deployment in a bifurcation.
    De Caro F; De Carlo M; Petronio AS
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e185-e188. PubMed ID: 25004004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19*2 genotyping.
    Alexopoulos D; Dimitropoulos G; Davlouros P; Xanthopoulou I; Kassimis G; Stavrou EF; Hahalis G; Athanassiadou A
    JACC Cardiovasc Interv; 2011 Apr; 4(4):403-10. PubMed ID: 21511219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic effect of clopidogrel therapy and switching to cilostazol in patients with the CYP2C19 loss-of-function allele (ACCEL-SWITCH) study.
    Jeong YH; Park Y; Muse WC; Kwon TJ; Koh JS; Hwang SJ; Kwak CH; Hwang JY
    J Thromb Haemost; 2012 Aug; 10(8):1685-8. PubMed ID: 22612904
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
    Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM;
    Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis).
    Valenti R; Marcucci R; Comito V; Marrani M; Cantini G; Migliorini A; Parodi G; Gensini GF; Abbate R; Antoniucci D
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1563-70. PubMed ID: 26386764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very late bioresorbable vascular scaffold thrombosis: a new clinical entity.
    Azzalini L; Al-Hawwas M; L'Allier PL
    EuroIntervention; 2015 May; 11(1):e1-2. PubMed ID: 25982486
    [No Abstract]   [Full Text] [Related]  

  • 8. Can we override clopidogrel resistance?
    Pena A; Collet JP; Hulot JS; Silvain J; Barthélémy O; Beygui F; Funck-Brentano C; Montalescot G
    Circulation; 2009 Jun; 119(21):2854-7. PubMed ID: 19487603
    [No Abstract]   [Full Text] [Related]  

  • 9. VERifyNow in DIabetes high-on-treatment platelet reactivity: a pharmacodynamic study on switching from clopidogrel to prasugrel.
    Cubero Gómez JM; Acosta Martínez J; Mendias Benítez C; Díaz De La Llera LS; Fernández-Quero M; Guisado Rasco A; Villa Gil-Ortega M; Sánchez González Á
    Acta Cardiol; 2015 Dec; 70(6):728-34. PubMed ID: 26717223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of the antiplatelet effect after switching to clopidogrel from initial prasugrel therapy in patients with acute coronary syndrome.
    Furuse E; Takano H; Yamamoto T; Kubota Y; Yoshizane T; Kitamura M; Miyachi H; Hosokawa Y; Shimizu W
    Heart Vessels; 2017 Dec; 32(12):1432-1438. PubMed ID: 28685204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute stent thrombosis owing to complete clopidogrel resistance successfully managed with prasugrel.
    Flaherty MP; Johnston PV; Rade JJ
    J Invasive Cardiol; 2011 Jul; 23(7):300-4. PubMed ID: 21725128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The excel stent: a good DES, but can we really stop clopidogrel after 6 months?
    Margolis JR
    JACC Cardiovasc Interv; 2009 Apr; 2(4):310-1. PubMed ID: 19463442
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized Comparison of Oral P2Y
    Hochholzer W; Kleiner P; Younas I; Valina CM; Löffelhardt N; Amann M; Bömicke T; Ferenc M; Hauschke D; Trenk D; Neumann FJ; Stratz C
    JACC Cardiovasc Interv; 2017 Jan; 10(2):121-129. PubMed ID: 28104204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between aspirin/clopidogrel resistance and intra-stent thrombi assessed by follow-up optical coherence tomography after drug-eluting stent implantation.
    Park J; Shin DH; Kim BK; Her AY; Kim YH; Choi HH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1181-6. PubMed ID: 23657678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Stent Deformation: Precise Diagnosis With Optical Coherence Tomography.
    Hernández-Matamoros H; Gonzálvez-Garcia A; Moreno-Gómez R; Jiménez-Valero S
    J Invasive Cardiol; 2019 Dec; 31(12):E395. PubMed ID: 31786534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel discontinuation and platelet reactivity following coronary stenting.
    Mylotte D; Peace AJ; Tedesco AT; Mangiacapra F; Dicker P; Kenny D; Foley DP
    J Thromb Haemost; 2011 Jan; 9(1):24-32. PubMed ID: 20961396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: a retrospective analysis of the FEATHER study.
    Jakubowski JA; Angiolillo DJ; Zhou C; Small DS; Moser BA; Ten Berg JM; Brown PB; James S; Winters KJ; Erlinge D
    Thromb Res; 2014 Sep; 134(3):552-7. PubMed ID: 25022828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.
    Trenk D; Hochholzer W; Frundi D; Stratz C; Valina CM; Bestehorn HP; Büttner HJ; Neumann FJ
    Thromb Haemost; 2008 Jan; 99(1):174-81. PubMed ID: 18217151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous subacute thrombosis of bare metal coronary stents in two different arteries early after clopidogrel cessation.
    Canpolat U; Yorgun H; Atalar E
    Cardiol J; 2012; 19(3):309-13. PubMed ID: 22641551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing platelet inhibition in clopidogrel poor metabolizers: therapeutic options and practical considerations.
    Angiolillo DJ; Ueno M
    JACC Cardiovasc Interv; 2011 Apr; 4(4):411-4. PubMed ID: 21511220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.